Evidence map›Paper›PMID 27443826›Full record

ArticleScientific reports2016

Maternal inflammation activated ROS-p38 MAPK predisposes offspring to heart damages caused by isoproterenol via augmenting ROS generation.

Qi Zhang, Yafei Deng, Wenjing Lai, Xiao Guan, Xiongshan Sun, Qi Han, Fangjie Wang, Xiaodong Pan, Yan Ji, Hongqin Luo and 9 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 53 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Mechanism of Action of Flavonoids ofMolecules (Basel, Switzerland) · 2022
    Article
  11. Article
  12. Cardiac Immunology: A New Era for Immune Cells in the Heart.Advances in experimental medicine and biology · 2021
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 3 countries.

Qi ZhangInstitute of Materia Medica, College of Pharmacy, Third Military Medical University, Chongqing 400038, China.
Yafei DengInstitute of Materia Medica, College of Pharmacy, Third Military Medical University, Chongqing 400038, China.
Wenjing LaiInstitute of Materia Medica, College of Pharmacy, Third Military Medical University, Chongqing 400038, China.
Xiao GuanInstitute of Materia Medica, College of Pharmacy, Third Military Medical University, Chongqing 400038, China.
Xiongshan SunInstitute of Materia Medica, College of Pharmacy, Third Military Medical University, Chongqing 400038, China.
Qi HanInstitute of Materia Medica, College of Pharmacy, Third Military Medical University, Chongqing 400038, China.
Fangjie WangInstitute of Materia Medica, College of Pharmacy, Third Military Medical University, Chongqing 400038, China.
Xiaodong PanInstitute of Materia Medica, College of Pharmacy, Third Military Medical University, Chongqing 400038, China.
Yan JiInstitute of Materia Medica, College of Pharmacy, Third Military Medical University, Chongqing 400038, China.
Hongqin LuoInstitute of Materia Medica, College of Pharmacy, Third Military Medical University, Chongqing 400038, China.
Pei HuangInstitute of Materia Medica, College of Pharmacy, Third Military Medical University, Chongqing 400038, China.
Yuan TangInstitute of Materia Medica, College of Pharmacy, Third Military Medical University, Chongqing 400038, China.
Liangqi GuThe Center for Disease Control and Prevention of Chengdu Military Command, Chengdu 610021, China.
Guorong DanInstitute of Materia Medica, College of Pharmacy, Third Military Medical University, Chongqing 400038, China.
Jianhua YuDivision of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio 43210, USA.
Michael NamakaColleges of Pharmacy and Medicine, University of Manitoba, Apotex Center 750, McDermot Avenue, Winnipeg, R3E 0T5, MB, Canada.
Jianxiang ZhangInstitute of Materia Medica, College of Pharmacy, Third Military Medical University, Chongqing 400038, China.
Youcai DengInstitute of Materia Medica, College of Pharmacy, Third Military Medical University, Chongqing 400038, China.
Xiaohui LiInstitute of Materia Medica, College of Pharmacy, Third Military Medical University, Chongqing 400038, China.
Army Medical University · CNLiaocheng Center for Disease Control and PreventionShantou University Medical College · CNThe Ohio State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Maternal inflammation contributes to the increased incidence of adult cardiovascular disease. The current study investigated the susceptibility of cardiac damage responding to isoproterenol (ISO) in adult offspring that underwent maternal inflammation (modeled by pregnant Sprague-Dawley rats with lipopolysaccharides (LPS) challenge). We found that 2 weeks of ISO treatment in adult offspring of LPS-treated mothers led to augmented heart damage, characterized by left-ventricular systolic dysfunction, cardiac hypertrophy and myocardial fibrosis. Mechanistically, prenatal exposure to LPS led to up-regulated expression of nicotinamide adenine dinucleotide phosphate (NADPH) oxidases, antioxidant enzymes, and p38 MAPK activity in left ventricular of adult offspring at resting state. ISO treatment exaggerated ROS generation, p38 MAPK activation but down-regulated reactive oxygen species (ROS) elimination capacity in the left ventricular of offspring from LPS-treated mothers, while antioxidant N-acetyl-L-cysteine (NAC) reversed these changes together with improved cardiac functions. The p38 inhibitor SB202190 alleviated the heart damage only via inhibiting the expression of NADPH oxidases. Collectively, our data demonstrated that prenatal inflammation programs pre-existed ROS activation in the heart tissue, which switches on the early process of oxidative damages on heart rapidly through a ROS-p38 MAPK-NADPH oxidase-ROS positive feedback loop in response to a myocardial hypertrophic challenge in adulthood.

Indexed as

AnimalsAntioxidantsFemaleHeartHeart DiseasesImidazolesInflammationIsoproterenolMaleNADPH OxidasesOxidative Stressp38 Mitogen-Activated Protein KinasesPregnancyPyridinesRatsRats, Sprague-Dawley4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazoleAntioxidantsImidazolesIsoproterenolNADPH Oxidasesp38 Mitogen-Activated Protein KinasesPyridinesReactive Oxygen Species

Identifiers

PMID27443826
PMCPMC4957145
OpenAlexW2498285394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.